
Impact of concomitant medication use on belimumab efficacy and safety in patients with systemic lupus erythematosus
Author(s) -
Schwarting,
Dooley,
Roth,
; Edwards,
David R. Thompson,
F. F. Wilson
Publication year - 2016
Publication title -
carolina digital repository (university of north carolina at chapel hill)
Language(s) - English
DOI - 10.17615/zst9-qe52
Subject(s) - belimumab , concomitant , medicine , systemic lupus , systemic therapy , dermatology , intensive care medicine , immunology , disease , antibody , b cell activating factor , cancer , breast cancer , b cell